Get alerts for new trials in your area by subscribing now
Active & Responsive
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
for
Melanoma, Soft Tissue Sarcoma
Location: Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 18 - 70+
Code: NCT05264974
Phase1, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Phoenix AZ, Jacksonville FL, Orlando FL, Atlanta GA,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase3, Recruiting
Active & Responsive
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
for
Melanoma, Unresectable Solid Tumors, Neoplasms,
Location: Chicago IL, Pittsburgh PA
Sponsor: Yana Najjar
Sex: All
Age: 18+
Code: NCT04572451
Phase1, Recruiting
Active & Responsive
Evaluation of Hypoxia in Primary Melanoma
for
Melanoma
Location: Pittsburgh PA
Sponsor: Yana Najjar
Sex: All
Age: 18+
Code: NCT06831071
Recruiting
Active & Responsive
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies